🇺🇸 FDA
Patent

US 11034740

Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use

granted A61KA61K2039/5256A61K2039/70

Quick answer

US patent 11034740 (Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/5256, A61K2039/70, A61K38/1709, A61K38/193